investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
The Role of FOXC1 in Basal-Like Breast Cancer
Xiaojiang Cui
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Michael Walter
University of Alberta
Edmonton, Canada
Xiaojiang Cui
Cedars-Sinai Medical Center
Los Angeles, United States
Related projects
Marcel Bally
Identifying Cytoprotective Responses Triggered Following Initial Exposure to Targeted Therapy: Defining Improved Treatment Strategies for Patients with HER-2 Positive Breast Cancer
Breast
Condeelis S John
Tumor microenvironments determing migration, dissemination and dormancy
Breast
Heide L Ford
Role of Six1 and the miR106b 25 Cluster in EMT and Tumor Progression
Breast
Ritu Aneja
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
Breast
Claudia Palena
Novel Targets for Vaccine Therapy
Breast
Fabio Petrocca
Noxa-mediated mechanisms of proteasome addiction in basal-like breast cancer
Breast
Richard G Pestell
Impact of Cyclin D1 Isoforms in Breast Cancer
Breast
Jose Baselga
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
Breast
Richard M Weinshilboum
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
Breast